Btg Pactual Global Asset Management LTD Vertex Pharmaceuticals Inc Transaction History

Btg Pactual Global Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $272,830 - $345,209	-1,796 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $612,549 - $703,886	-3,652 Reduced 67.03%	1,796 $346,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $85,829 - $100,106	589 Added 12.12%	5,448 $926,000
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $47,905 - $55,973	316 Added 6.96%	4,859 $792,000
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $21,141 - $23,954	154 Added 3.51%	4,543 $681,000
Q3 2017 Nov 14, 2017	SELL	$148.13 - $162.24 $51,252 - $56,135	-346 Reduced 7.31%	4,389 $667,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,735	4,735 $610,000

1,725

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $104B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.